AVU0

Adverum Biotechnologies INC

+$32.7M

Net Activity

Institutions Holding

49

Popularity Rank

#5800

Avg Weight

0.43%

Total Value

$61.7M

Ownership Trend

49 institutions currently hold AVU0, with 21 net buyers and 49 net sellers this quarter.

Institutional Moves

Institutional Moves (Q3 2025)

Majority Decreased

Based on recent trading activity

Net Selling Institutions

49

Net Buying Institutions

21

Key Holders

View all 49 holding institutions

Quarterly Activity

Recent Activity

+$38.0M

Total Buy Value

$38.1M

Total Sell Value

New buy13
Trim18
Add8
Sold out31

21

Net Buyers

49

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding ADVERUM BIOTECHNOLOGIES INC (AVU0)?
Major stakeholders currently include BML Capital Management, LLC ($13.9M), Principia Wealth Advisory, LLC ($9.4M), Frazier Life Sciences Management, L.P. ($9.4M). Based on the latest 13F filings, there are a total of 49 tracked investment funds and institutions maintaining positions in AVU0.
What is the overall institutional sentiment toward AVU0 recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $32.7M, driven by 21 managers accumulating shares while 49 reduced their exposure.
Which institutions have been selling or reducing their AVU0 positions?
In the latest period, 18 funds trimmed their holdings, and 31 managers completely exited their positions. The aggregate reported sell value was $38.1M.
Are there any notable investors adding AVU0 to their portfolios?
Yes, buying activity remains notable. 13 institutions opened new positions in {ticker}, and 8 existing holders added to their shares. The total reported buy value for the quarter amounted to $38.0M.

Related Stocks